## Abbreviations
[CrossRef]
* (71) [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. _Int. Immunopharmacol._**2014**, _21_, 447-455. [CrossRef] [PubMed]* _[PERSON] et al. (2016)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway. _Oncol. Rep._**2016**, _35_, 2880-2886. [CrossRef]
* _[PERSON] et al. (2015)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Schisandrin B suppresses glioma cell metastasis mediated by inhibition of mTOR/MMP-9 signal pathway. _Biomed. Pharmacother._**2015**, _74_, 77-82. [CrossRef] [PubMed]
* _[PERSON] et al. (2017)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-kB/MMP-9 signaling. _PLoS ONE_**2017**, _12_, e0173725. [CrossRef] [PubMed]
* _[PERSON] et al. (1999)_ [PERSON] [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON]; [PERSON] P-glycoprotein-mediated resistance to chemotherapy in cancer cells: Using recombinant cytosolic domains to establish structure-function relationships. _Braz. J. Med. Biol. Res._**1999**, _32_, 925-939. [CrossRef] [PubMed]
* _[PERSON] et al. (2018)_ [PERSON]; [PERSON]; [PERSON]; [PERSON] [PERSON] The challenge of drug resistance in cancer treatment: A current overview. _Clin. Exp. Metastasis_**2018**, _35_, 309-318. [CrossRef] [PubMed]
* _[PERSON] et al. (2017)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] The different mechanisms of cancer drug resistance: A brief review. _Adv. Pharm. Bull._**2017**, \(7\), 339-348. [CrossRef]
* _[PERSON] et al. (2008)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] _Salmonella enterica_ serovar Typhimurium modulates P-glycoprotein in the intestinal epithelium. _Am. J. Physiol. Gastrointest. Liver Physiol._**2008**, _294_, G1392-G1400. [CrossRef] [PubMed]
* _[PERSON] et al. (2015)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Immunomodulatory protein from _Ganderna microsporum_ induces pro-death autophagy through Akt-mTOR-p7056K pathway inhibition in multidrug resistant lung cancer cells. _PLoS ONE_**2015**, _10_, e0125774. [CrossRef] [PubMed]
* _[PERSON] et al. (2016)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Resveratrol increases anti-proliferative activity of Bestatin through downregulating P-Glycoprotein expression via inhibiting PI3K/Akt/mTOR pathway in K562/ADR cells. _J. Cell Biochem._**2016**, _117_, 1233-1239. [CrossRef]
* _[PERSON] et al. (2016)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; etal. A _Salmonella_ nanoparticle mimic overcomes multidrug resistance in tumours. _Nat. Commun._**2016**, \(7\), 12225. [CrossRef] [PubMed]
* _[PERSON] et al. (2007)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Tumor-targeting _Salmonella typhimurium_ improves cyclophosphamide chemotherapy at maximum tolerated dose and low-dose metronomic regimens in a murine melanoma model. _Int. J. Cancer_**2007**, _121_, 666-674. [CrossRef]
* _[PERSON] et al. (2018)_ [PERSON]; [PERSON]; [PERSON]; [PERSON] _Salmonella_ immunotherapy improves the outcome of CHOP chemotherapy in non-Hodgkin lymphoma-bearing mice. _Front. Immunol._**2018**, \(9\), 7. [CrossRef] [PubMed]
* _[PERSON] et al. (2016)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Tumor relapse prevented by combining adoptive T cell therapy with _Salmonella typhimurium. Oncoinmunology_**2016**, \(5\), e1130207. [CrossRef] [PubMed]
* _[PERSON] et al. (2018)_ [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON]; [PERSON] Bacteria-driven hypoxia targeting for combined biotherapy and photothermal therapy.